Press release content from PR Newswire. The AP news staff was not involved in its creation.
Caris Life Sciences Announces Appointment of Joseph E. Gilliam to Board of Directors
April 28, 2021 GMT
Caris Life Sciences Logo (PRNewsfoto/Caris Life Sciences)
IRVING, Texas, April 28, 2021 /PRNewswire/ Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced the appointment of Joseph E. Gilliam to the Caris Board of Directors, effective April 12, 2021. Following the appointment of Mr. Gilliam, the Board will be comprised of 10 directors.
The Caris Life Sciences Board of Directors is responsible for the overall management of the company, including guiding strategies and monitoring company performance. The Caris Board is composed of a diverse group of leaders with distinct perspectives. Many of the current directors have held leadership roles at major domestic and international compani
Caris Life Sciences to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference 2021
News provided by
Share this article
Share this article
IRVING, Texas, Feb. 9, 2021 /PRNewswire/ Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence, focused on fulfilling the promise of precision medicine, announced today that David D. Halbert, Chairman and Chief Executive Officer, Brian J. Brille, Vice Chairman, David Spetzler, MS, MBA, Ph.D., President and Chief Scientific Officer and Thomas Parker, Senior Vice President and Chief Financial Officer will host a fireside chat at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference February 17, 2021, at 4:00 p.m. Eastern time.